Craft

Novogene

Revenue

¥2.2 B

FY, 2025

Novogene Summary

Company Summary

Overview
Novogene (北京诺禾致源科技股份有限公司) is a company specializing in genomics and bioinformatics research solutions. It offers genome sequencing, transcriptome sequencing, pre-made library sequencing, epigenomics, and metagenomics, as well as clinical diagnostics and biopharma services. Novogene caters to drug development, food science, medical treatment, and other sectors.
Type
Public
Status
Active
Founded
2011
HQ
Beijing, CN | view all locations
Website
https://www.novogene.com/eu-en/
Cybersecurity rating
Sectors

Key People

  • Ruiqiang Li

    Ruiqiang Li, Founder

    • Shifang Zhang

      Shifang Zhang, President, Novogene Corporation

    • Zhisheng Cao

      Zhisheng Cao, Vice President Operations, Novogene Corporation

    Operating MetricsView all

    Services Provided

    4

    May, 2023

    Applications

    9

    May, 2023

    Partners

    36

    May, 2023

    LocationsView all

    8 locations detected

    • Beijing, Beijing Shi HQ

      China

      Building 301, Zone A10 Jiuxianqiao North Road, Chaoyang District

    • Sacramento, CA

      United States

      2921 Stockton Blvd #1810

    • Planegg, BY

      Germany

      Am Klopferspitz 19a

    • Hong Kong, Kowloon

      Hong Kong

      Unit 1307, Everglory Centre, 1B Kimberley Street, Tsim Sha Tsui

    • Tokyo, Tokyo

      Japan

      Nagaoka BLDG3-7F, 2-7-10, Nihonbashi-Kayabacho, Chuo City

    • Singapore

      Singapore

      11 Biopolis Wy, #10-11

    and 2 others

    Novogene Financials

    Summary Financials

    Revenue (Q1, 2026)
    ¥555.0M
    Gross profit (Q1, 2026)
    ¥231.4M
    Net income (Q1, 2026)
    ¥32.0M
    Cash (Q1, 2026)
    ¥334.7M
    EBIT (Q1, 2026)
    ¥37.4M

    Footer menu